Cholesterol lowering in intermediate-risk persons without cardiovascular disease (2016)
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, FÁRMACOS (SISTEMA CARDIOVASCULAR), ADESÃO À MEDICAÇÃO, HIPERCOLESTEROLEMIA, FARMACOTERAPIA
ABNT
YUSUF, S. et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, v. 374, n. 21, p. 2021-2031, 2016Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1600176. Acesso em: 14 out. 2024.APA
Yusuf, S., Marin Neto, J. A., Gao, P., Diaz, R., & Lonn, E. (2016). Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, 374( 21), 2021-2031. doi:10.1056/NEJMoa1600176NLM
Yusuf S, Marin Neto JA, Gao P, Diaz R, Lonn E. Cholesterol lowering in intermediate-risk persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2021-2031.[citado 2024 out. 14 ] Available from: https://doi.org/10.1056/NEJMoa1600176Vancouver
Yusuf S, Marin Neto JA, Gao P, Diaz R, Lonn E. Cholesterol lowering in intermediate-risk persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2021-2031.[citado 2024 out. 14 ] Available from: https://doi.org/10.1056/NEJMoa1600176